A jury in Georgia has ordered Monsanto parent Bayer to pay nearly $2.1 billion in damages to a man who says the company’s Roundup
weed killer caused his cancer, according to attorneys representing the plaintiff.
The verdict marks the latest in a long-running series of court battles Monsanto
has faced over its Roundup herbicide. The agrochemical giant says
it will appeal the verdict, reached in a Georgia courtroom late Friday, in efforts to overturn the decision.
The penalties awarded include $65 million in compensatory damage
s and $2 billion in punitive damages, law firms Arnold & Itkin LLP and Kline & Specter PC said in a statement. That marks one of the lar
gest verdicts in a Roundup-related case to date.
Related:
Bayer Threatens to Stop Roundup Weedkiller Sales in US Over Litigation Costs
Bayer Broadens Effort to Shield Itself From Claims Weedkiller Caused Cance
Bayer Must Pay $78 Million in Latest Roundup Cancer Trial, Jury Finds
Watch More Image Part 2 >>>
Judge Cuts Bayer $2.25 Billion Roundup Verdict to $400 Million
Plaintiff John Barnes filed his lawsuit against Monsanto in 2021, seeking damages related to his non-Hodgkin’s lymphoma. Arnold & Itk
in attorney Kyle Findley, the lead trial lawyer on the case, said the verdict will help put his client in a better position to get the treatment he needs going forward.
“It’s been a long road for him … and he was happy that the truth related to t
he product (has) been exposed,” Findley told The Associated Press on Sunday. He called the verdict an “important milestone
” after “another example of Monsanto’s refusal to accept responsibility for poisoning people with this toxic product.”
Germany-based Bayer, which acquired Monsanto in 2018, has continued to dispute claims that Roundup causes cancer. But the
company has been hit with more than 177,000 lawsuits involving the weedkiller and set aside $16 billion to settle cases.
In a statement, Monsanto said Friday’s verdict “conflicts with the overwhelming weight of scientific evidence and the consensus of regulatory bodies and their scientific assessments worldwide.” The company added that it continues “to stand fully behind the safety” of Roundup products.
For a variety of crops — including corn, soybeans and cotton — Roundup is designed to work with genetically modified seeds that resist the weedkiller’s deadly effect. It allows farmers to produce more while conserving the soil by tilling it less.
Some studies associate Roundup’s key ingredient, glyphosate, with cancer, although the U.S. Environmental Protection Agency has said it is not likely to be carcinogenic to humans when used as directed. Still, numerous lawsuits over the weedkiller allege glyphosate does cause non-Hodgkin lymphoma, arguing that Monsanto has failed to warn the public about serious risks for years.